Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.

The POU transcription factor OCT4 is a pleiotropic regulator of gene expression in embryonic stem cells. Recent studies demonstrated that OCT4 is aberrantly expressed in multiple types of human cancer; however, the underlying molecular mechanism remains largely unknown. In this study, we report that OCT4-pg4, a pseudogene of OCT4, is abnormally activated in hepatocellular carcinoma (HCC). The expression level of OCT4-pg4 is positively correlated with that of OCT4, and both gene transcripts can be directly targeted by a tumor-suppressive micro RNA miR-145. We find that the non-coding RNA OCT4-pg4 is biologically active, as it can upregulate OCT4 protein level in HCC. Mechanistic analysis revealed that OCT4-pg4 functions as a natural micro RNA sponge to protect OCT4 transcript from being inhibited by miR-145. In addition, our study also showed that OCT4-pg4 can promote growth and tumorigenicity of HCC cells, thus exerting an oncogenic role in hepatocarcinogenesis. Furthermore, survival analysis suggests that high OCT4-pg4 level is significantly correlated with poor prognosis of HCC patients. Taken together, our finding adds a new layer of post-transcriptional regulation of OCT4 and sheds new light on the treatment of human HCC.

[1]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[2]  D. Pei Regulation of Pluripotency and Reprogramming by Transcription Factors* , 2009, Journal of Biological Chemistry.

[3]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[4]  H. Schöler,et al.  Absence of OCT4 Expression in Somatic Tumor Cell Lines , 2008, Stem cells.

[5]  N. Wong,et al.  Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. , 2003, Journal of hepatology.

[6]  Y. Bergman,et al.  Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.

[7]  G. Chirn,et al.  Multiple Retropseudogenes from Pluripotent Cell-specific Gene Expression Indicates a Potential Signature for Novel Gene Identification* , 2005, Journal of Biological Chemistry.

[8]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[9]  E. Punch,et al.  Pseudogenes: pseudo-functional or key regulators in health and disease? , 2011, RNA.

[10]  A. Hao,et al.  Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma , 2011, The Journal of pathology.

[11]  N. Wong,et al.  MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. , 2012, Carcinogenesis.

[12]  S. Dhanasekaran,et al.  Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers , 2012, Cell.

[13]  Jingjing Liu,et al.  MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4 , 2012, PloS one.

[14]  Beth Israel,et al.  Decision letter: Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010 .

[15]  T. Mueller,et al.  Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells , 2009, Cellular and Molecular Life Sciences.

[16]  P. Andrews,et al.  Specific Knockdown of Oct4 and β2‐microglobulin Expression by RNA Interference in Human Embryonic Stem Cells and Embryonic Carcinoma Cells , 2004, Stem cells.

[17]  X. Wang,et al.  Clinical implications of cancer stem cell biology in hepatocellular carcinoma. , 2012, Seminars in oncology.

[18]  C. Croce,et al.  MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.

[19]  R. Montironi,et al.  OCT4: biological functions and clinical applications as a marker of germ cell neoplasia , 2007, The Journal of pathology.

[20]  D. Steinemann,et al.  Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions , 2008, Modern Pathology.

[21]  C. Holding,et al.  Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.

[22]  Yi Shen,et al.  Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. , 2012, Frontiers in bioscience.

[23]  S. Gitelman,et al.  Abundant adrenal-specific transcription of the human P450c21A "pseudogene". , 1993, The Journal of biological chemistry.

[24]  G. McCaughan,et al.  Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin‐6 signaling , 2008, Hepatology.

[25]  Frank J. Sørensen,et al.  Diagnostic and prognostic microRNAs in stage II colon cancer. , 2008, Cancer research.

[26]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[27]  Oliver H. Tam,et al.  Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes , 2008, Nature.

[28]  H. Schöler,et al.  The molecular biology of Oct-4 in the early mouse embryo. , 1998, Molecular human reproduction.

[29]  A. Iwama,et al.  Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. , 2007, Gastroenterology.

[30]  S. Byers,et al.  Liver stem cells and hepatocellular carcinoma , 2009, Hepatology.

[31]  P. Lu,et al.  Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway , 2010, Hepatology.

[32]  Hong-Yang Wang,et al.  p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. , 2012, Gastroenterology.

[33]  F. Wang,et al.  Octamer 4 Small Interfering RNA Results in Cancer Stem Cell-Like Cell Apoptosis , 2012 .

[34]  Yvonne Tay,et al.  MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation , 2009, Nature.

[35]  S. Qiu,et al.  Coexpression of Stemness Factors Oct4 and Nanog Predict Liver Resection , 2012, Annals of Surgical Oncology.

[36]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[37]  Y. Atlasi,et al.  OCT‐4, an embryonic stem cell marker, is highly expressed in bladder cancer , 2007, International journal of cancer.

[38]  Peter Schirmacher,et al.  MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.

[39]  J. Miyazaki,et al.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells , 2000, Nature Genetics.

[40]  P. Brown,et al.  Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma , 2012, Nature Reviews Gastroenterology &Hepatology.

[41]  M. Todesco,et al.  Target mimicry provides a new mechanism for regulation of microRNA activity , 2007, Nature Genetics.

[42]  P. Lu,et al.  Octamer 4 ( Oct 4 ) Mediates Chemotherapeutic Drug Resistance in Liver Cancer Cells Through a Potential Oct 4 – AKT – ATP-Binding Cassette G 2 Pathway , 2010 .

[43]  J. Lou,et al.  Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. , 2012, Oncology reports.

[44]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[45]  Jin Han,et al.  Oct4 pseudogenes are transcribed in cancers. , 2005, Biochemical and biophysical research communications.

[46]  E. Lai,et al.  The long and short of inverted repeat genes in animals: MicroRNAs, mirtrons and hairpin RNAs , 2008, Cell cycle.

[47]  P. Gimotty,et al.  Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation , 2012, Oncogene.

[48]  H. Schöler,et al.  Stem cell pluripotency and transcription factor Oct4 , 2002, Cell Research.

[49]  G. Pan,et al.  MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.

[50]  A. Clark,et al.  Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma , 2005, Cancer.

[51]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.